denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
Hematology Disease Topics & Pathways:
Research, Translational Research, Clinical Practice (Health Services and Quality), Treatment Considerations, Adverse Events
Session: MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
Hematology Disease Topics & Pathways:
Research, Translational Research, Clinical Practice (Health Services and Quality), Treatment Considerations, Adverse Events
Sunday, December 8, 2024, 9:30 AM-10:45 AM
Disclosures: Kiladjian: Novartis: Consultancy; GSK: Consultancy; AOP Health: Consultancy; Incyte: Membership on an entity's Board of Directors or advisory committees; Abbvie: Honoraria; PharmaEssentia: Honoraria.
OffLabel Disclosure: Off label use of pegylated interferon alpha in essential thrombocythemia and myelofibrosis
See more of: MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
See more of: Education Program
See more of: Education Program